|
|
Volumn 11, Issue 21, 2012, Pages 3913-
|
|
Cyclin-dependent kinase 4/6 inhibition in cancer therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 ACETYL 8 CYCLOPENTYL 5 METHYL 2 [5 (1 PIPERAZINYL) 2 PYRIDINYLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE;
CYCLIN DEPENDENT KINASE 4;
CYCLIN DEPENDENT KINASE 6;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
KI 67 ANTIGEN;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BREAST CANCER;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER THERAPY;
CELL CYCLE G1 PHASE;
CELL CYCLE S PHASE;
CYTOTOXICITY;
DNA DAMAGE;
DNA SYNTHESIS;
HUMAN;
MYELOMA CELL;
NOTE;
PATHOGENESIS;
PROTEIN EXPRESSION;
TRIPLE NEGATIVE BREAST CANCER;
|
|
EID: 84869457757
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.22390 Document Type: Note |
|
Times cited : (19)
|
|
References (9)
|
